Screening strategies are needed, as is further research on appropriate therapeutic approach.
In a study, 85.5% of advanced CKD patients opted for renal replacement therapy.
Other risk factors include reduced muscle mass and lower levels of physical activity.
A model incorporating 4 factors had greater power to predict dialysis initiation than renal function alone.
A plant-based diet might one day prove to be an option for kidney disease patients.
Significant mean reduction in oxycodone, noroxycodone arterial concentrations.
Death risk similar for patients on twice-weekly and thrice-week hemodialysis.
Metformin-associated 1-year risk of acute dialysis increased by 50.3 per 100,000 individuals.
Mortality risk is similar whether starting treatment with 1 or 2 sessions per week or with the conventional 3 sessions per week.
Patients who took CVD medications less than 60% of the time before starting dialysis had a 21% increased risk of early death after dialysis initiation.
The availability of direct-acting antiviral drugs may enable eradication of hepatitis C virus and improve outcomes.
Average weekly doses greater than 70 µg/week was associated with a 77% increased risk of cancer compared with no ESA exposure.
Recent studies have cast doubt on the universal superiority of the conventional approach to dialysis.
Assisted peritoneal dialysis and in-center hemodialysis are associated with similar hospitalization rates.
Study also links smoking with a decreased likelihood of receiving a kidney transplant.
Hypomagnesemia in the presence of inflammation is associated with increased 1-year death risk.
Only 40% of older patients transitioning to maintenance dialysis were on renin-angiotensin system blockade.
Small trial suggests device might be feasible, potentially freeing patients from dialysis machines,
Researchers found that eGFR decline decelerated significantly in patients with AVF/AVG, from -5.6 to -4.1 mL/min/1.73m2 per year.
Phosphorus levels are higher when blood specimens are collected after weekends.
Patients were 40% less likely to die in 2011 compared with 2001, study finds.
The risk is most elevated among individuals aged 44 years or younger.
Investigators find that the normalized mean ESA dose decreases as patients' elevation of residence increases.
The positive trend is more pronounced among established patients than those who recently started dialysis.
Researchers linked the condition to warfarin use, diabetes, obesity, recurrent skin trauma, and derangements in mineral metabolism.
In-hospital mortality risk was more than double among patients whose hyperkalemia persisted than those whose potassium levels normalized.
Treatment linked to improved long-term survival, regardless of underlying kidney function.
Findings from a small study suggest that periodontal disease may be a relevant contributing factor.
Iranian study of hemodialysis patients with secondary hyperparathyroidism finds no significant correlation.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)